NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 217 filers reported holding NPS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $25,483,000 | +26.4% | 712,420 | -8.1% | 0.05% | +19.5% |
Q3 2014 | $20,161,000 | -51.6% | 775,441 | -38.5% | 0.04% | -51.8% |
Q2 2014 | $41,659,000 | +37.0% | 1,260,499 | +24.1% | 0.08% | +28.8% |
Q1 2014 | $30,411,000 | +51.2% | 1,016,062 | +53.4% | 0.07% | +46.7% |
Q4 2013 | $20,112,000 | +361.1% | 662,439 | +383.1% | 0.04% | +309.1% |
Q3 2013 | $4,362,000 | +119.6% | 137,133 | +4.3% | 0.01% | +120.0% |
Q2 2013 | $1,986,000 | – | 131,530 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 549,425 | $16,680,000 | 6.89% |
Opaleye Management Inc. | 205,000 | $5,945,000,000 | 4.67% |
Rhenman & Partners Asset Management AB | 240,000 | $7,286,000 | 2.85% |
SECTORAL ASSET MANAGEMENT INC | 1,774,919 | $53,887,000 | 2.32% |
Eventide Asset Management | 242,700 | $7,368,000 | 2.27% |
OAK RIDGE INVESTMENTS LLC | 2,713,717 | $82,389,000 | 2.16% |
First Light Asset Management, LLC | 68,245 | $2,072,000 | 1.76% |
Broadfin Capital, LLC | 400,000 | $12,144,000 | 1.60% |
Cupps Capital Management, LLC | 748,175 | $22,714,000 | 1.54% |
FCG ADVISORS, LLC | 70,651 | $2,145,000 | 1.45% |